Subthreshold opioid use disorder prevention trial (CTN-0101). DSC5 contract. 09/20/2019 - 11/16/2020. N01DA-19-2250.
Ended Awarded Last action
- Contract number
- 75N95019F00097
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,884,166
Award facts
- Opportunity
-
- 75N95019R00016 Solicitation number
- Contract value 100% obligated
- $1,884,166.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Exercise an Option | $245,168 | |
| Exercise an Option | $245,168 | |
| Change Order | $743,886 | |
| Original award | $649,944 |
About this award
The Emmes Company LLC was awarded a delivery order against the National Institute on Drug Abuse Data, Statistics, and Clinical Trial Support Center multiple award contract vehicle to conduct the SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL. Valued at $1,884,166, this cost-plus-fixed-fee contract will support the clinical trial through February 2025. As the prime, Emmes will leverage its expertise in clinical research and trial support to deliver services for the National Institutes of Health National Institute on Drug Abuse initiative aimed at developing prevention strategies for opioid use disorder. No set aside designation was specified. The award demonstrates the Health and Human Services agency's continued focus on addressing the nation's opioid crisis through research conducted by experienced contractors.
Quick answers
Who was awarded contract 75N95019F00097?
75N95019F00097 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2019.
How much is contract 75N95019F00097 worth?
The government has obligated $1,884,166 on 75N95019F00097.
Is contract 75N95019F00097 an order under another contract?
Yes. 75N95019F00097 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95019F00097 competed?
The extent of competition for 75N95019F00097 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award